9 Bilder zum Thema "rna dependent rna polymerase" bei ClipDealer

Medien sortieren nach     Gehe zu Seite:    
« Vorherige  1  Nächste »
The SARS-CoV-2 RNA dependent RNA polymerase is a promising target for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 7BTF
The nucleotide analog remdesivir blocks the SARS-CoV-2 RNA dependent RNA polymerase and is a promising drug for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 7BTF
The nucleotide analog remdesivir blocks the SARS-CoV-2 RNA dependent RNA polymerase and is a promising drug for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 7BTF
The SARS-CoV-2 RNA dependent RNA polymerase is a promising target for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 7BTF
Potential drug target proteins of coronavirus SARS-CoV-2: from left, spike protein, RNA polymerase, main protease. PDB entries: 6vsb, 7btf, 6lu7.
Potential drug target proteins of coronavirus SARS-CoV-2: from upper left to right: spike protein, RNA polymerase, main protease with an inhibitor bound. PDB entries: 6vsb, 7btf, 6lu7.
The SARS-CoV-2 RNA dependent RNA polymerase with an RNA fragment bound. It is a promising target for the treatment of COVID-19.. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 6yy7
Rifampicin capsule for treatment tuberculosis and leprosy. Antibiotic resistance of tuberculosis (TB). Antituberculosis drug. Red pills produce reddish coloration of urine, sweat, sputum, and tears.
Sofosbuvir molecular structure isolated on white

« Vorherige  1  Nächste »